United Capital Financial Advisers LLC lessened its stake in Colgate-Palmolive (NYSE:CL) by 28.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 494,004 shares of the company’s stock after selling 194,817 shares during the period. United Capital Financial Advisers LLC owned 0.06% of Colgate-Palmolive worth $35,405,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently bought and sold shares of CL. Profund Advisors LLC grew its stake in shares of Colgate-Palmolive by 10.3% during the second quarter. Profund Advisors LLC now owns 16,731 shares of the company’s stock worth $1,199,000 after acquiring an additional 1,562 shares during the last quarter. Crabel Capital Management LLC grew its stake in shares of Colgate-Palmolive by 59.3% during the second quarter. Crabel Capital Management LLC now owns 5,515 shares of the company’s stock worth $395,000 after acquiring an additional 2,054 shares during the last quarter. Scotia Capital Inc. grew its stake in shares of Colgate-Palmolive by 4.6% during the second quarter. Scotia Capital Inc. now owns 87,826 shares of the company’s stock worth $6,295,000 after acquiring an additional 3,892 shares during the last quarter. APG Asset Management N.V. grew its stake in shares of Colgate-Palmolive by 24.4% during the second quarter. APG Asset Management N.V. now owns 2,359,646 shares of the company’s stock worth $148,504,000 after acquiring an additional 462,062 shares during the last quarter. Finally, Captrust Financial Advisors grew its stake in shares of Colgate-Palmolive by 52.1% during the second quarter. Captrust Financial Advisors now owns 6,839 shares of the company’s stock worth $490,000 after acquiring an additional 2,342 shares during the last quarter. Institutional investors own 76.64% of the company’s stock.
Shares of CL traded down $1.73 during trading hours on Friday, hitting $70.56. 2,621,588 shares of the stock were exchanged, compared to its average volume of 2,697,233. The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.78 and a current ratio of 1.13. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $76.41. The company has a market cap of $61.88 billion, a price-to-earnings ratio of 23.76, a price-to-earnings-growth ratio of 4.64 and a beta of 0.75. The stock’s 50-day moving average price is $72.68 and its two-hundred day moving average price is $70.84.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 26th. The company reported $0.72 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.72. Colgate-Palmolive had a negative return on equity of 10,821.98% and a net margin of 14.77%. The firm had revenue of $3.87 billion during the quarter, compared to analysts’ expectations of $3.88 billion. During the same period in the previous year, the business earned $0.77 earnings per share. The firm’s revenue for the quarter was down .5% on a year-over-year basis. On average, research analysts expect that Colgate-Palmolive will post 2.84 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Wednesday, October 23rd will be given a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 2.44%. The ex-dividend date is Tuesday, October 22nd. Colgate-Palmolive’s payout ratio is 57.91%.
A number of brokerages have recently weighed in on CL. ValuEngine lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Wells Fargo & Co boosted their price target on Colgate-Palmolive from $68.00 to $70.00 and gave the stock a “market perform” rating in a research note on Monday, July 29th. Morgan Stanley boosted their price target on Colgate-Palmolive from $72.00 to $74.00 and gave the stock an “equal weight” rating in a research note on Monday, July 29th. Citigroup boosted their price target on Colgate-Palmolive from $77.00 to $79.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 20th. Finally, UBS Group lifted their target price on Colgate-Palmolive from $80.00 to $82.00 and gave the stock a “buy” rating in a report on Monday, July 29th. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $73.87.
In related news, CFO Henning I. Jakobsen sold 33,854 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $73.45, for a total transaction of $2,486,576.30. Following the completion of the sale, the chief financial officer now directly owns 73,693 shares in the company, valued at $5,412,750.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP John J. Huston sold 473 shares of the business’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $72.93, for a total value of $34,495.89. Following the sale, the senior vice president now owns 59,668 shares of the company’s stock, valued at $4,351,587.24. The disclosure for this sale can be found here. Insiders have sold 546,050 shares of company stock valued at $39,291,054 over the last quarter. 1.14% of the stock is owned by company insiders.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Read More: How to interpret the current ratio
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.